Literature DB >> 22453672

Robotic-assisted and laparoscopic sacrocolpopexy: comparing operative times, costs and outcomes.

Jasmine Tan-Kim1, Shawn A Menefee, Karl M Luber, Charles W Nager, Emily S Lukacz.   

Abstract

OBJECTIVES: : To compare operative times, hospital costs, and surgical outcomes for robotic-assisted laparoscopic sacrocolpopexy (RALSC) and laparoscopic sacrocolpopexy (LSC).
METHODS: : A retrospective cohort study of 104 subjects who underwent RALSC (n = 43) or LSC (n = 61) for vaginal vault prolapse was performed. The primary outcomes were operative time and hospital costs. The secondary outcomes included blood loss, complications, and objective cure rates. χ and t tests were used.
RESULTS: : The mean operative time was longer in RALSC than in LSC (281 ± 58 vs 206 ± 42 minutes; P < 0.001) with setup time accounting for only 9 minutes of this difference. Direct costs (expressed in cost units) for hospital stay were similar (437 ± 88 vs 450 ± 119 units; P = 0.738) while surgical costs remained higher for RALSC (2724 ± 413 vs 2295 ± 342 units; P < 0.01). Blood loss and complications were similar, and objective cure was not significantly different for RALSC vs LSC (90% vs 80%, P = 0.19).
CONCLUSIONS: : Robotic-assisted laparoscopic sacrocolpopexy achieves similar perioperative outcomes compared to LSC with increased surgical time resulting in increased costs.

Entities:  

Year:  2011        PMID: 22453672     DOI: 10.1097/SPV.0b013e3181fa44cf

Source DB:  PubMed          Journal:  Female Pelvic Med Reconstr Surg        ISSN: 2151-8378            Impact factor:   2.091


  18 in total

Review 1.  Robotic versus laparoscopic sacrocolpopexy for treatment of prolapse of the apical segment of the vagina: a systematic review and meta-analysis.

Authors:  Maribel De Gouveia De Sa; Leica Sarah Claydon; Barry Whitlow; Maria Angelica Dolcet Artahona
Journal:  Int Urogynecol J       Date:  2015-08-07       Impact factor: 2.894

2.  A pilot study comparing anatomic failure after sacrocolpopexy with absorbable or permanent sutures for vaginal mesh attachment.

Authors:  Jasmine Tan-Kim; Shawn A Menefee; Quinn Lippmann; Emily S Lukacz; Karl M Luber; Charles W Nager
Journal:  Perm J       Date:  2014

Review 3.  Robotic Sacrocolpopexy-Is It the Treatment of Choice for Advanced Apical Pelvic Organ Prolapse?

Authors:  Janine L Oliver; Ja-Hong Kim
Journal:  Curr Urol Rep       Date:  2017-09       Impact factor: 3.092

Review 4.  Robotic pelvic organ prolapse surgery.

Authors:  Kamran P Sajadi; Howard B Goldman
Journal:  Nat Rev Urol       Date:  2015-03-24       Impact factor: 14.432

5.  Laparoscopic sacrocolpopexy: operative times and efficiency in a high-volume female pelvic medicine and laparoscopic surgery practice.

Authors:  Robert Moore; Christopher Moriarty; Orawee Chinthakanan; John Miklos
Journal:  Int Urogynecol J       Date:  2016-10-20       Impact factor: 2.894

6.  Trainee performance at robotic console and benchmark operative times.

Authors:  Andrea K Crane; Elizabeth J Geller; Catherine A Matthews
Journal:  Int Urogynecol J       Date:  2013-05-03       Impact factor: 2.894

Review 7.  Outcomes of robotic sacrocolpopexy: a systematic review and meta-analysis.

Authors:  Catherine O Hudson; Gina M Northington; Robert H Lyles; Deborah R Karp
Journal:  Female Pelvic Med Reconstr Surg       Date:  2014 Sep-Oct       Impact factor: 2.091

8.  Introduction of laparoscopic sacral colpopexy to a fellowship training program.

Authors:  Kelly Kantartzis; Gary Sutkin; Dan Winger; Li Wang; Jonathan Shepherd
Journal:  Int Urogynecol J       Date:  2013-04-03       Impact factor: 2.894

9.  The effect of surgical start time in patients undergoing minimally invasive sacrocolpopexy.

Authors:  Karl Jallad; Matthew D Barber; Beri Ridgeway; Marie Fidela R Paraiso; Cecile A Unger
Journal:  Int Urogynecol J       Date:  2016-03-30       Impact factor: 2.894

10.  New "Wrinkle Method" for Intracorporeal Anterior Vaginal Wall Plication during Sacrocolpopexy.

Authors:  Sa Ra Lee; Ju Hee Kim; Sung Hoon Kim; Hee Dong Chae
Journal:  J Clin Med       Date:  2021-04-22       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.